申请人:Lynch Kevin R.
公开号:US20080318901A1
公开(公告)日:2008-12-25
The present invention is directed to compositions comprising lysophosphatidic acid analogs and methods of using such analogs as agonist or antagonists of LPA receptor activity. In addition the invention is directed to LPA receptor agonists that vary in the degree of selectivity at individual LPA receptors (i.e. LPA1, LPA2 and LPA3). More particularly the present invention is directed to LPA analogs wherein the glycerol is replaced with ethanolamine and a variety of substitutions have been linked at the second carbon atom.
本发明涉及包含溶血磷脂酸类似物的组合物以及使用这些类似物作为LPA受体活性的激动剂或拮抗剂的方法。此外,本发明涉及在单个LPA受体(即LPA1,LPA2和LPA3)的选择度方面有所不同的LPA受体激动剂。更具体地,本发明涉及LPA类似物,其中甘油被乙醇胺取代,并且在第二个碳原子上连接了各种替代基。